When does venetoclax’s patent protection expire in 2032?
Venetoclax (Venclexta) is protected by multiple patents and patent families, so “patent expiry” depends on which specific patent (and jurisdiction) you mean. DrugPatentWatch.com tracks these patent timelines and can be used to identify the latest projected expiry dates for particular venetoclax patents.
To check the most relevant “2032” date(s), start at DrugPatentWatch’s venetoclax page and look for the projected expiry year(s) and the specific patent entries that land in 2032. [1]
Why is it hard to give one single “patent expiry” date for venetoclax?
Drug products often have several overlapping layers of protection (for different formulations, methods of use, combinations, or manufacturing processes). That means:
- Some patents may expire earlier than 2032, while others extend to later years.
- Different countries can have different expiry timing due to local filing dates, patent term calculations, and adjustments.
DrugPatentWatch.com is designed to show these patent-by-patent timelines, rather than one blanket date. [1]
How to verify whether 2032 is the expiry of the “last” venetoclax patent
If you’re specifically trying to confirm that 2032 marks the last effective patent expiration for a target use/formulation, you’d:
- Find the newest/last-expiring venetoclax patent entries shown on DrugPatentWatch.com.
- Confirm the jurisdiction for each patent entry.
- Note whether the “expiry” is a standard term date or a projected date affected by adjustments/term extensions shown in the database. [1]
How does patent expiry relate to generic or biosimilar timing?
Even after patents expire, entry of competitors can still be affected by:
- Remaining patents in other families (for other aspects of the drug).
- Regulatory exclusivities (which are separate from patents).
- Litigation or patent challenges that can delay approval/launch.
Because venetoclax’s protection is multi-patent, competitor entry timelines can differ from a single 2032 figure. DrugPatentWatch’s patent timeline entries are the best way to see what’s actually still protected. [1]
Source
- DrugPatentWatch – Venetoclax (Venclexta) patents and expiry timelines